Top-News
  • Watchlist
  • Glocke

  • CAC 40 Index

    7.795,86 +0,49% +37,8716
    06.06.25 22:05:23 Ariva Indikation aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 969400
    ISIN: FR0003500008
    Typ: Index

    Weiter aufwärts? Long handeln - Jetzt mit Hebel 12,01: MK4STF
    Werbung

    Ad-hocs

    15.04.25 - GlobeNewswire
    Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
    Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show efficacy in heterogeneous ...
    08.04.25 - GlobeNewswire
    Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
    Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in ...
    07.04.25 - GlobeNewswire
    Availability of the explanatory documentation for the Combined General Meeting of April 29, 2025
    Paris, April 7, 2025 Press release Availability of the explanatory documentation for the Combined General Meeting of April 29, 2025 The Combined General Meeting of shareholders ...
    07.04.25 - GlobeNewswire
    ArcelorMittal announces the commencement of a new share buyback program over the period 2025-2030
    7 April 2025, 08:30 CET
    04.04.25 - GlobeNewswire
    ArcelorMittal announces updated financial calendar for 2025
    4 April 2025, 18:00 CET
    04.04.25 - GlobeNewswire
    ArcelorMittal publishes convening notice for its Annual General Meeting of shareholders
    4 April 2025, 08:00 CET
    03.04.25 - GlobeNewswire
    Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
    Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines Designation granted for warm autoimmune hemolytic anemia and IgG4-...
    02.04.25 - GlobeNewswire
    ArcelorMittal announces the completion of its 85 million shares buyback program
    2 April 2025, 10:30 CET
    01.04.25 - GlobeNewswire
    Share buyback program
    L'Oréal announced to have today entered into a mandate with an investment services provider for the purchase of its own shares, under the authorisation approved by the Annual ...
    28.03.25 - GlobeNewswire
    Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
    Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first antithrombin-​lowering therapy in hemophilia, offers ...
    28.03.25 - GlobeNewswire
    Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
    Dupixent approved as the first-​ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal ...
    27.03.25 - GlobeNewswire
    ArcelorMittal announces publication of the 2024 statutory financial statements of ArcelorMittal parent company
    27 March 2025, 17:45 CET
    26.03.25 - GlobeNewswire
    Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
    Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to ...
    25.03.25 - GlobeNewswire
    Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
    Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
    24.03.25 - GlobeNewswire
    Annual General Meeting to be held on Tuesday 29 April 2025 and 2024 Universal Registration Document
    L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Tuesday 29 April 2025 and the 2024 ...
    24.03.25 - GlobeNewswire
    Press Release: Availability of the Q1 2025 Aide mémoire
    Availability of the Q1 2025 Aide mémoire Paris, France – March 24, 2025 . Sanofi announced today that its Q1 2025 Aide mémoire is available on the "Investors" page of the ...
    21.03.25 - GlobeNewswire
    Unibail-Rodamco-Westfield: Availability of the 2024 Universal Registration Document and terms for holding the Combined General Meeting of Unibail-Rodamco-Westfield SE on April 29, 2025
    Paris, March 21, 2025 Press release Availability of the 2024 Universal Registration Document and terms for holding the Combined General Meeting of Unibail-​Rodamco-Westfield ...
    20.03.25 - GlobeNewswire
    Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
    Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to ...
    10.03.25 - GlobeNewswire
    ArcelorMittal announces the publication of its 2024 annual report
    10 March 2025, 23.55 CET
    10.03.25 - GlobeNewswire
    ArcelorMittal publishes its Annual Report 2024 on Form 20-F
    ArcelorMittal has filed its Annual Report 2024 on Form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is now available at ...

    Newssuche

    Videos

    newspaper
    05.06.25 -3,92%
    Technical Trading: Gold Zukauf Chance
    Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 7 Laufzeit: OpenEnd Einstieg: Market ... Mehr »